Literature DB >> 25549536

RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1.

Amit A Kulkarni1, Ganesh Boora, Rahul Kanwar, Kathryn J Ruddy, Michaela S Banck, Nguyet Le-Lindqwister, Terry M Therneau, Charles L Loprinzi, Andreas S Beutler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25549536      PMCID： PMC4490132          DOI： 10.3109/0284186X.2014.985388

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  8 in total

Review 1.  Genome-wide association studies for complex traits: consensus, uncertainty and challenges.

Authors:  Mark I McCarthy; Gonçalo R Abecasis; Lon R Cardon; David B Goldstein; Julian Little; John P A Ioannidis; Joel N Hirschhorn
Journal:  Nat Rev Genet       Date:  2008-05       Impact factor: 53.242

2.  GWAS-based association between RWDD3 and TECTA variants and paclitaxel induced neuropathy could not be confirmed in Scandinavian ovarian cancer patients.

Authors:  Troels K Bergmann; Werner Vach; Søren Feddersen; Lise Eckhoff; Henrik Gréen; Jørn Herrstedt; Kim Brosen
Journal:  Acta Oncol       Date:  2012-08-09       Impact factor: 4.089

3.  Using extreme phenotype sampling to identify the rare causal variants of quantitative traits in association studies.

Authors:  Dalin Li; Juan Pablo Lewinger; William J Gauderman; Cassandra Elizabeth Murcray; David Conti
Journal:  Genet Epidemiol       Date:  2011-09-15       Impact factor: 2.135

Review 4.  Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics.

Authors:  Guido Cavaletti; Paola Alberti; Paola Marmiroli
Journal:  Lancet Oncol       Date:  2011-06-28       Impact factor: 41.316

5.  The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20.

Authors:  T J Postma; N K Aaronson; J J Heimans; M J Muller; J G Hildebrand; J Y Delattre; K Hoang-Xuan; M Lantéri-Minet; R Grant; R Huddart; C Moynihan; J Maher; R Lucey
Journal:  Eur J Cancer       Date:  2005-04-14       Impact factor: 9.162

6.  Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy.

Authors:  Andreas S Beutler; Amit A Kulkarni; Rahul Kanwar; Christopher J Klein; Terry M Therneau; Rui Qin; Michaela S Banck; Ganesh K Boora; Kathryn J Ruddy; Yanhong Wu; Regenia L Smalley; Julie M Cunningham; Nguyet Anh Le-Lindqwister; Peter Beyerlein; Gary P Schroth; Anthony J Windebank; Stephan Züchner; Charles L Loprinzi
Journal:  Ann Neurol       Date:  2014-09-17       Impact factor: 10.422

7.  Detecting rare variant effects using extreme phenotype sampling in sequencing association studies.

Authors:  Ian J Barnett; Seunggeun Lee; Xihong Lin
Journal:  Genet Epidemiol       Date:  2012-11-26       Impact factor: 2.135

8.  Why most published research findings are false.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.613
  8 in total
  7 in total

Review 1.  Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview.

Authors:  Alexandre Chan; Daniel L Hertz; Manuel Morales; Elizabeth J Adams; Sharon Gordon; Chia Jie Tan; Nathan P Staff; Jayesh Kamath; Jeong Oh; Shivani Shinde; Doreen Pon; Niharkia Dixit; James D'Olimpio; Cristina Dumitrescu; Margherita Gobbo; Kord Kober; Samantha Mayo; Linda Pang; Ishwaria Subbiah; Andreas S Beutler; Katherine B Peters; Charles Loprinzi; Maryam B Lustberg
Journal:  Support Care Cancer       Date:  2019-07-30       Impact factor: 3.603

2.  Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance).

Authors:  Ganesh K Boora; Amit A Kulkarni; Rahul Kanwar; Peter Beyerlein; Rui Qin; Michaela S Banck; Kathryn J Ruddy; Josef Pleticha; Cynthia A Lynch; Robert J Behrens; Stephan Züchner; Charles L Loprinzi; Andreas S Beutler
Journal:  J Neurol Sci       Date:  2015-06-27       Impact factor: 3.181

3.  Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neurotoxicity.

Authors:  Eleonora Pozzi; Paola Alberti
Journal:  Methods Mol Biol       Date:  2022

4.  Neurological safety of oxaliplatin in patients with uncommon variants in Charcot-Marie-tooth disease genes.

Authors:  Jennifer G Le-Rademacher; Camden L Lopez; Rahul Kanwar; Brittny Major-Elechi; Alexej Abyzov; Michaela S Banck; Terry M Therneau; Jeff A Sloan; Charles L Loprinzi; Andreas S Beutler
Journal:  J Neurol Sci       Date:  2020-01-14       Impact factor: 3.181

Review 5.  Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems.

Authors:  Nathan P Staff; Jill C Fehrenbacher; Martial Caillaud; M Imad Damaj; Rosalind A Segal; Sandra Rieger
Journal:  Exp Neurol       Date:  2019-11-21       Impact factor: 5.330

6.  A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol.

Authors:  Anukriti Sharma; Ken B Johnson; Bihua Bie; Emily E Rhoades; Alper Sen; Yuri Kida; Jennifer Hockings; Alycia Gatta; Jacqueline Davenport; Connie Arcangelini; Jennifer Ritzu; Jennifer DeVecchio; Ron Hughen; Mei Wei; G Thomas Budd; N Lynn Henry; Charis Eng; Joseph Foss; Daniel M Rotroff
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

7.  Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy.

Authors:  Annelot G J van Rossum; Marleen Kok; Danielle McCool; Mark Opdam; Nienke C Miltenburg; Ingrid A M Mandjes; Elise van Leeuwen-Stok; Alex L T Imholz; Johanneke E A Portielje; Monique M E M Bos; Aart van Bochove; Erik van Werkhoven; Marjanka K Schmidt; Hendrika M Oosterkamp; Sabine C Linn
Journal:  Oncotarget       Date:  2017-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.